Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study

In 1961, a randomized study was begun at the University of Wisconsin Medical Center in which the treatment of advanced squamous cell carcinoma of the head and neck with radiation therapy was compared with combined treatment with radiation therapy and 5-Fluorouracil. One hundred and thirty-six patients with primary lesions in the oral cavity, the base of the tongue, and the oropharynx were analyzed. Both local control and survival were better in the combined treatment group than in the group with radiation therapy alone. However, in only the oral cavity patient population was the difference statistically significant. Both acute and late complications were also increased in this group of patients who received combined treatment.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Psyrri, M. Kwong, S. DiStasio, L. Lekakis, M. Kassar, C. Sasaki, L.D. Wilson, B.G. Haffty, Y.H. Son, D.A. Ross, et al. Cisplatin, Fluorouracil, and Leucovorin Induction Chemotherapy Followed by Concurrent Cisplatin Chemoradiotherapy for Organ Preservation and Cure in Patients With Advanced Head and Neck Cancer: Long-Term Follow-Up J. Clin. Oncol., August 1, 2004; 22(15): 3061 - 3069. [Abstract] [Full Text] [PDF]

				Y. Ichinose, Y. Nakai, S. Kudoh, H. Semba, S. Yoshida, T. Nukiwa, H. Yamamoto, Y. Yamane, and H. Niitani Uracil/Tegafur Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Multi-institutional Phase II Trial Clin. Cancer Res., July 1, 2004; 10(13): 4369 - 4373. [Abstract] [Full Text] [PDF]

				T. A. Rich, R. C. Shepard, and S. T. Mosley Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy J. Clin. Oncol., June 1, 2004; 22(11): 2214 - 2232. [Abstract] [Full Text] [PDF]

				A. Argiris, D. J. Haraf, M. S. Kies, and E. E. Vokes Intensive Concurrent Chemoradiotherapy for Head and Neck Cancer with 5-Fluorouracil- and Hydroxyurea-Based Regimens: Reversing a Pattern of Failure Oncologist, August 1, 2003; 8(4): 350 - 360. [Abstract] [Full Text] [PDF]

				D. J. Adelstein, Y. Li, G. L. Adams, H. Wagner Jr, J. A. Kish, J. F. Ensley, D. E. Schuller, and A. A. Forastiere An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer J. Clin. Oncol., January 1, 2003; 21(1): 92 - 98. [Abstract] [Full Text] [PDF]

				O Pradier, K Eberlein, E Weiss, M C Jackel, and C F Hess Radiotherapy combined with simultaneous chemotherapy with mitomycin-C and 5-fluorouracil for inoperable head and neck cancer Br. J. Radiol., April 1, 2001; 74(880): 368 - 374. [Abstract] [Full Text] [PDF]

				A. S. Garden, B. S. Glisson, K. K. Ang, W. H. Morrison, S. M. Lippman, R. M. Byers, F. Geara, G. L. Clayman, D. M. Shin, D. L. Callender, et al. Phase I/II Trial of Radiation With Chemotherapy ""Boost"" for Advanced Squamous Cell Carcinomas of the Head and Neck: Toxicities and Responses J. Clin. Oncol., August 1, 1999; 17(8): 2390 - 2390. [Abstract] [Full Text] [PDF]

				L. Milas, T. Fujii, N. Hunter, M. Elshaikh, K. Mason, W. Plunkett, K. K. Ang, and W. Hittelman Enhancement of Tumor Radioresponse in Vivo by Gemcitabine Cancer Res., January 1, 1999; 59(1): 107 - 114. [Abstract] [Full Text] [PDF]

				E. E. Vokes, R. R. Weichselbaum, S. M. Lippman, and W. K. Hong Head and Neck Cancer N. Engl. J. Med., January 21, 1993; 328(3): 184 - 194. [Full Text]